FDA Inspection
Dynalabs LLCDynalabs LLC – FDA Inspection, Sep 26, 2019
Record Details
This FDA Inspection record concerns Dynalabs LLC, with an inspection on September 26, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Emilie Kahn (Issuing Officer)
- Michael G. Truchan (FDA Associated Person)
- Nicole A. Lloyd (FDA Associated Person)
View Company Profile
ID · f24ba632-872d-456d-a4ec-1dc99efadb84
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1103093
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.166(a)(3)Valid stability test methods
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dynalabs LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 13, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Dynalabs LLC
- FDA Inspection 883544 - 2014-06-12
- FDA Inspection 808001 - 2012-11-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.